Adam Friedman, M.D., Ph.D.

Dr. Friedman has served as Scorpion Therapeutics’ Chief Executive Officer since January 2024. Previously, he served as President, Corporate Strategy and Business Development.

Dr. Friedman is an accomplished physician, scientist, and life sciences entrepreneur with extensive experience in oncology. Prior to helping to found Scorpion, he was Director of Corporate Development at Raze Therapeutics, a company he co-founded and President and Chief Executive Officer of Vivid Biosciences, an oncology platform discovery company that he founded. Dr. Friedman was also an entrepreneur-in-residence at Atlas Venture. He received his B.A. in molecular biology from Princeton University and received both his M.D. and Ph.D. in genetics from Harvard Medical School and was subsequently trained clinically in pediatrics and cancer biology.